Clinical Trial Update: Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigated the safety and effect of ergocalciferol supplementation on erythropoietin dosing in patients with end-stage renal disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Erythropoietin (erythropoietin)
• ergocalciferol (ergocalciferol)

Snippet

Sponsor: Dialysis Clinic, Inc. | Conditions: End Stage Renal Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-03-14